These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12047498)

  • 61. Newer anticonvulsants in the treatment of bipolar disorder.
    Yatham LN
    J Clin Psychiatry; 2004; 65 Suppl 10():28-35. PubMed ID: 15242330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal.
    Schik G; Wedegaertner FR; Liersch J; Hoy L; Emrich HM; Schneider U
    Addict Biol; 2005 Sep; 10(3):283-8. PubMed ID: 16109591
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oxcarbazepine treatment for paroxetine-induced restless leg syndrome.
    Oztürk O; Eraslan D; Kumral E
    Gen Hosp Psychiatry; 2006; 28(3):264-5. PubMed ID: 16675374
    [No Abstract]   [Full Text] [Related]  

  • 65. Practical aspects of oxcarbazepine treatment.
    Dam M
    Epilepsia; 1994; 35 Suppl 3():S23-5. PubMed ID: 8156977
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extended-release carbamazepine capsules : in bipolar I disorder.
    Swainston Harrison T; Keating GM
    CNS Drugs; 2005; 19(8):709-16. PubMed ID: 16097852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
    Sporn J; Ghaemi SN; Sambur MR; Rankin MA; Recht J; Sachs GS; Rosenbaum JF; Fava M
    Ann Clin Psychiatry; 2000 Sep; 12(3):137-40. PubMed ID: 10984002
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
    Homberg V; Kowalik A; Schulze-Bonhage A
    Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oxcarbazepine treatment during breast-feeding: a case report.
    Lutz UC; Wiatr G; Gaertner HJ; Bartels M
    J Clin Psychopharmacol; 2007 Dec; 27(6):730-2. PubMed ID: 18004156
    [No Abstract]   [Full Text] [Related]  

  • 71. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
    Pauletto G; Bergonzi P;
    Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction.
    Soskin DP; Kane AJ; Stern TA
    Psychosomatics; 2010; 51(6):532-5. PubMed ID: 21051688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anticonvulsants in the treatment of bipolar disorder.
    Keck PE; McElroy SL; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):395-405. PubMed ID: 1422166
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review.
    Kaufman KR; Gerner R
    Epilepsy Behav; 2003 Dec; 4(6):766-70. PubMed ID: 14698716
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
    Shukla G; Gupta A; Agarwal P; Poornima S
    Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA; Kalali AH; Weisler RH;
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gabapentin treatment of mood disorders: a preliminary study.
    Ghaemi SN; Katzow JJ; Desai SP; Goodwin FK
    J Clin Psychiatry; 1998 Aug; 59(8):426-9. PubMed ID: 9721823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.